We wish Rezon Bio and the entirety of its dynamic team who collaborated on the new brand great success in 2026. Check them out at www.rezonbio.com.
We wish Rezon Bio and the entirety of its dynamic team who collaborated on the new brand great success in 2026. Check them out at www.rezonbio.com.
The 2026 sterile market is hot as hell, and the commercial investment into Afton Scientific by Arlington Capital (and the team at That’s Nice) couldn’t be more pleased. Check them out at www.aftonscientific.com.
Protagene, an Ampersand Capital portfolio company, is on the cutting edge of proteomix. We’ve always loved working with this team, and we wish them all the best in the coming year. Check them out at www.protagene.com.
DataHow has just timed the AI/ML market perfectly, as 2026 is, of course, slated to be the year of AI. Check them out at www.datahow.ch.
DIANT Pharma is moving into year five, and the LNP market is picking up. Let’s capitalize on that forward momentum in 2026. Check them out at www.diantpharma.com.
YourBio Health was purchased by Hims & Hers in 2025 from Flagship Pioneering. So, when your GLP-1 injections are virtually painless, these are the guys to thank. Check them out at www.yourbiohealth.com.
With $1.5 Billion raised, the FS2 team continues to expand and will launch its Wilmington, NC, facility in Q1 2026. Can’t wait to see the final product. Check them out at www.fs2.com.
Yourway continued to grow its privately held supply chain logistics business in 2025 and is always looking ahead. Keep doing what you’re doing in 2026. Check them out at www.yourway.com.
FAB Biopharma continues to look for investment, and we are in full support. Here’s to making great strides in women’s health in 2026. Check them out at www.fabbiopharma.com.
TriRx consolidated its business in 2025, and we are looking forward to spurring growth again in 2026, with Tim Tyson as the ever-strong CEO. Check them out at www.trirx.com.